Emerald Health Therapeutics, Inc. appointed Chris Wagner as Chief Executive Officer, Rob Hill as Chief Financial Officer, and Paul Dillman as Vice President Sales & Marketing. Mr. Wagner spent more than 25 years in marketing pharmaceutical products and building biotechnology companies, including 10 years with Eli Lily. Mr. Hill brings over 20 years of accounting, finance, and senior leadership experience as a seasoned manager of private and publicly traded technology and financial services businesses in Canada, USA and Asia.

Mr. Dillman brings three decades of experience in global consumer product marketing, sales, and general management.